Ratings by Truist Securities (Danielle Brill)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/31/2026 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2026 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2026 | Jefferson Capital | JCAP | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2026 | Apogee Therapeutics Inc | APGE | Maintain | Hold (N/A) |
|
Details | ||
| 8/12/2026 | Upstream Bio | UPB | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2026 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2026 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2026 | Dianthus Therapeutics | DNTH | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2026 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2026 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2026 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2026 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2026 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2026 | Biogen | BIIB | Upgrade | Buy (Hold) |
199.15 (216.04) |
8.48% | Details | |
| 6/10/2026 | Dianthus Therapeutics | DNTH | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/27/2026 | Apogee Therapeutics Inc | APGE | Maintain | Hold (N/A) |
|
Details | ||
| 5/27/2026 | Vertex | VRTX | New Coverage | Buy (N/A) |
434.52 (547.65) |
26.04% | Details | |
| 5/22/2026 | Immunovant | IMVT | Maintain | Hold (N/A) |
|
Details | ||
| 5/18/2026 | Rapport Therapeutics | RAPP | New Coverage | Buy (N/A) |
37.07 (48.56) |
31% | Details | |
| 5/13/2026 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2026 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Hold (N/A) |
|
Details | ||
| 5/6/2026 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2026 | Biogen | BIIB | Maintain | Hold (N/A) |
|
Details | ||
| 4/29/2026 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2026 | WAVE Life Sciences | WVE | New Coverage | Buy (N/A) |
6.94 (4.97) |
-28.39% | Details | |
| 4/27/2026 | Biogen | BIIB | Maintain | Hold (N/A) |
|
Details | ||
| 4/13/2026 | Maze Therapeutics | MAZE | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2026 | Biogen | BIIB | Maintain | Hold (N/A) |
|
Details | ||
| 4/13/2026 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2026 | Centessa Pharmaceuticals | CNTA | Downgrade | Hold (Buy) |
39.76 (40.50) |
1.86% | Details | |
| 4/7/2026 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 4/2/2026 | Upstream Bio | UPB | Maintain | Buy (N/A) |
|
Details | ||
| 4/2/2026 | Immunovant | IMVT | Maintain | Hold (N/A) |
|
Details | ||
| 3/25/2026 | Maze Therapeutics | MAZE | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2026 | Apogee Therapeutics Inc | APGE | Maintain | Hold (N/A) |
|
Details | ||
| 3/17/2026 | Apogee Therapeutics Inc | APGE | New Coverage | Hold (N/A) |
71.09 (135.08) |
90.01% | Details | |
| 3/17/2026 | Climb Bio | CLYM | New Coverage | Buy (N/A) |
7.13 (14.82) |
107.85% | Details | |
| 3/17/2026 | Maze Therapeutics | MAZE | New Coverage | Buy (N/A) |
51.26 (26.53) |
-48.24% | Details | |
| 3/9/2026 | Dianthus Therapeutics | DNTH | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2026 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2026 | BridgeBio Pharma | BBIO | Maintain | (N/A) |
|
Details | ||
| 2/24/2026 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2026 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Hold (N/A) |
|
Details | ||
| 2/20/2026 | Harmony Biosciences Holdings Inc. | HRMY | Downgrade | Hold (Buy) |
34.39 (41.25) |
19.95% | Details | |
| 2/17/2026 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2026 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2026 | Immunovant | IMVT | Maintain | Hold (N/A) |
|
Details | ||
| 2/9/2026 | Biogen | BIIB | Maintain | Hold (N/A) |
|
Details | ||
| 1/29/2026 | Centessa Pharmaceuticals | CNTA | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2026 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2025 | Insmed | INSM | New Coverage | Buy (N/A) |
198.46 (121.51) |
-38.77% | Details | |
| 12/15/2025 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2025 | Jefferson Capital | JCAP | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2025 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2025 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | Centessa Pharmaceuticals | CNTA | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2025 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2025 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 10/17/2025 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 10/17/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2025 | Dianthus Therapeutics | DNTH | New Coverage | Buy (N/A) |
34.42 (106.62) |
209.76% | Details | |
| 10/14/2025 | Upstream Bio | UPB | New Coverage | Buy (N/A) |
20.08 (6.55) |
-67.38% | Details | |
| 10/14/2025 | Immunovant | IMVT | New Coverage | Hold (N/A) |
17.35 (39.90) |
129.97% | Details | |
| 10/2/2025 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 9/15/2025 | argenx SE | ARGX | New Coverage | Buy (N/A) |
756.39 (1028.51) |
35.98% | Details | |
| 9/10/2025 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 9/2/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 8/20/2025 | Centessa Pharmaceuticals | CNTA | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/21/2025 | Biogen | BIIB | New Coverage | Hold (N/A) |
124.99 (199.15) |
59.33% | Details | |
| 7/21/2025 | Tectonic Therapeutics Inc. | TECX | New Coverage | Buy (N/A) |
21.91 (31.22) |
42.49% | Details | |
| 7/21/2025 | Centessa Pharmaceuticals | CNTA | New Coverage | Buy (N/A) |
15.69 (39.76) |
153.41% | Details | |
| 7/21/2025 | Disc Medicine | IRON | New Coverage | Buy (N/A) |
57.77 (78.67) |
36.18% | Details | |
| 7/21/2025 | Jefferson Capital | JCAP | New Coverage | Buy (N/A) |
16.70 (20.67) |
23.77% | Details | |
| 7/21/2025 | Neurocrine Bio. | NBIX | New Coverage | Buy (N/A) |
132.02 (156.76) |
18.74% | Details | |
| 7/21/2025 | Palvella Therapeutics | PVLA | New Coverage | Buy (N/A) |
29.51 (150.55) |
410.17% | Details | |
| 7/21/2025 | Alnylam Pharmaceuticals | ALNY | New Coverage | Buy (N/A) |
320.53 (246.11) |
-23.22% | Details | |
| 7/21/2025 | BridgeBio Pharma | BBIO | New Coverage | Buy (N/A) |
46.51 (76.57) |
64.63% | Details | |
| 7/21/2025 | Harmony Biosciences Holdings Inc. | HRMY | New Coverage | Buy (N/A) |
35.20 (41.25) |
17.19% | Details |
